Maxymune Therapeutics, Inc. — Form D/A
Maxymune Therapeutics, Inc. of LOS ALTOS, CA, a company, filed a Form D amendment with the SEC on 2026-06-03. The offering totals $4.5M, of which $2.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-06-03
- Form: D/A
- Accession: 0002058052-26-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.5M
- Amount sold: $2.7M
- Remaining: $1.8M
- Minimum investment: $10K
- Investors: 15
- Revenue range: No Revenues
- SEC file number: 021-539494
Issuer
- Name: Maxymune Therapeutics, Inc.
- CIK: 0002058052
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 95 MAIN ST. SUITE 9, LOS ALTOS, CA, 94022
- Phone: 650-892-1942
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Tatjana Naranda | Related Person | Los Altos, CA |
| Gordon Ringold | Related Person | Truckee, CA |
| Neil Solomons | Related Person | Victoria, A1 |
| Tatjana Naranda | Executive Officer | Los Altos, CA |
| Neil Solomons | Director | Victoria, A1 |
| Gordon Ringold | Director | Truckee, CA |
| Gordon Ringold | Executive Officer | Truckee, CA |
Other filings by this issuer (1)
More